217 related articles for article (PubMed ID: 20851061)
1. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria.
Van Acker H; Van Snick E; Nelis HJ; Coenye T
J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria.
Peeters E; Nelis HJ; Coenye T
J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000
[TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms.
Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M
J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284
[TBL] [Abstract][Full Text] [Related]
4. Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium.
Peeters E; Nelis HJ; Coenye T
J Antimicrob Chemother; 2008 May; 61(5):1062-5. PubMed ID: 18310047
[TBL] [Abstract][Full Text] [Related]
5. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
Kitt H; Lenney W; Gilchrist FJ
BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
[TBL] [Abstract][Full Text] [Related]
6.
Narayanaswamy VP; Duncan AP; LiPuma JJ; Wiesmann WP; Baker SM; Townsend SM
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910901
[No Abstract] [Full Text] [Related]
7. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms.
Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664
[TBL] [Abstract][Full Text] [Related]
8. Social interactions in the Burkholderia cepacia complex: biofilms and quorum sensing.
Coenye T
Future Microbiol; 2010 Jul; 5(7):1087-99. PubMed ID: 20632807
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm.
Pollini S; Di Pilato V; Landini G; Di Maggio T; Cannatelli A; Sottotetti S; Cariani L; Aliberti S; Blasi F; Sergio F; Rossolini GM; Pallecchi L
PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348
[TBL] [Abstract][Full Text] [Related]
10. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A; Gyi KM; Hodson ME
J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
[TBL] [Abstract][Full Text] [Related]
11. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia.
Treerat P; Widmer F; Middleton PG; Iredell J; George AM
FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356
[TBL] [Abstract][Full Text] [Related]
12. Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria.
Papaleo MC; Fondi M; Maida I; Perrin E; Lo Giudice A; Michaud L; Mangano S; Bartolucci G; Romoli R; Fani R
Biotechnol Adv; 2012; 30(1):272-93. PubMed ID: 21742025
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
[TBL] [Abstract][Full Text] [Related]
14. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.
Messiaen AS; Nelis H; Coenye T
J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients.
Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V
Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526
[TBL] [Abstract][Full Text] [Related]
16. Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives.
Messiaen AS; Verbrugghen T; Declerck C; Ortmann R; Schlitzer M; Nelis H; Van Calenbergh S; Coenye T
Int J Antimicrob Agents; 2011 Sep; 38(3):261-4. PubMed ID: 21724375
[TBL] [Abstract][Full Text] [Related]
17. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans.
Caraher E; Duff C; Mullen T; Mc Keon S; Murphy P; Callaghan M; McClean S
J Cyst Fibros; 2007 Jan; 6(1):49-56. PubMed ID: 16781896
[TBL] [Abstract][Full Text] [Related]
18. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
Fraser-Pitt D; Mercer D; Lovie E; Robertson J; O'Neil D
Antimicrob Agents Chemother; 2016 Oct; 60(10):6200-6. PubMed ID: 27503654
[TBL] [Abstract][Full Text] [Related]
19. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.
De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA
J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.
Caraher E; Reynolds G; Murphy P; McClean S; Callaghan M
Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):213-6. PubMed ID: 17265071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
